Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo

scientific article published on 01 August 1995

Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo is …
instance of (P31):
scholarly articleQ13442814

External links are
P953full work available at URLhttp://intl-jpet.aspetjournals.org/cgi/content/abstract/274/2/866
P698PubMed publication ID7636750

P2093author name stringI. Lucki
D. S. Kreiss
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)866-876
P577publication date1995-08-01
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titleEffects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo
P478volume274

Reverse relations

cites work (P2860)
Q246435115-HT(1A) receptor function in major depressive disorder
Q24651067Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions
Q34886531Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system
Q42378356Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas
Q36879560Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.
Q74126285Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study
Q46767739Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells.
Q42077495Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography
Q35822361DSP-1053, a novel serotonin reuptake inhibitor with 5-HT1A partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats
Q37276935Differential regulation of serotonin-1A receptor-stimulated [35S]GTP gamma S binding in the dorsal raphe nucleus by citalopram and escitalopram
Q35047176Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors
Q44367469Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex
Q38028902Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
Q35042302Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Q71312103Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors
Q33935828Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta
Q33514619Fluoxetine and sertraline attenuate postischemic brain injury in mice
Q43540497Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Q46431169Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test
Q73692022In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors
Q36401400Innovative approaches for the development of antidepressant drugs: current and future strategies
Q26827615Molecular and genetic basis of depression
Q30453028Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use.
Q47569133Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders
Q45081784Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats
Q37230927Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant
Q35109908Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective
Q21129279Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved
Q36547548Serotonergic dysfunction: brain imaging and behavioral correlates
Q27015917Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder
Q58697569Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy
Q44085203Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
Q37000551Sigma receptors [σRs]: biology in normal and diseased states
Q42521024The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram
Q36825752The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
Q34265971The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
Q92353023The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression
Q21132285The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats
Q35682947The serotonergic system and anxiety
Q28602109cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats

Search more.